Skip to main content
. 2023 Apr 26;9:67. doi: 10.1038/s41531-023-00507-y

Fig. 4. The correlation between delayed MIBG H/M and clinical indices in the high-risk subjects.

Fig. 4

Pearson’s correlation test comparing the delayed MIBG H/M ratio and motor (a) and cognitive (be) functions as well as non-motor symptoms (fh) in the participants. MIBG metaiodobenzylguanidine, MDS-UPDRS Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale, MoCA-J the Japanese version of the Montreal Cognitive Assessment, OSIT-J the odor stick identification test for Japanese, SCOPA-AUT the Japanese version of the Scale for Outcomes in Parkinson’s disease for Autonomic Symptoms; RBDSQ RBD screening scale.